rs10860227 (RMST): Novel C-Reactive Protein Locus

Key takeaways

• rs10860227, in the RMST-PAFAH1B2P2 chromosomal region, was identified as a novel locus for C-reactive protein (CRP) levels - a blood marker of systemic inflammation - through a large multi-trait genome-wide study.
• The study combined CRP data with five cardiometabolic traits (HDL cholesterol, LDL cholesterol, triglycerides, body mass index, and cigarettes per day) using a method called MTAG to boost statistical power.
• Evidence for this locus comes from one published study; independent replication has not been described in the available source material, making the finding preliminary.
• The broader analysis found 797 independent genetic signals across 283 loci, with 41 being entirely novel to CRP research, placing this locus within a still-growing genetic map of inflammation.
• No effect size specific to rs10860227 is reported in the provided study text.

What the research says A 2022 multi-trait analysis of genome-wide association studies (MTAG) - a statistical method that jointly models correlated traits to increase detection power - combined CRP with high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, triglycerides (blood fats), body mass index (BMI), and cigarettes per day (CPD), identifying 797 independent genetic signals across 283 loci at genome-wide significance (p < 5 x 10^-8, the standard false-positive control threshold for large-scale genetic studies), including 41 novel CRP loci. Of the loci found, 41 colocalized (shared a likely causal genetic signal) between CRP and the cardiometabolic risk factors, and 12 of these showed discordant effects - meaning the direction of the genetic influence differed between CRP and the paired cardiometabolic trait - a pattern that also appeared as opposing associations with clinical outcomes in follow-up phenome-wide analyses (PheWAS, a method that tests a variant against many health outcomes simultaneously). The rs10860227 variant, in the RMST-PAFAH1B2P2 region, was identified within this multi-trait discovery framework as one of the novel CRP loci.

Reported associations

• C-reactive protein (CRP) levels: This locus was identified as a novel genetic signal for circulating CRP levels through the MTAG framework. No effect size (such as a beta coefficient or proportion of variance explained) specific to rs10860227 is available in the provided study text.
• Cardiometabolic pleiotropy (shared genetic effects across traits): The study found that many CRP loci overlap with signals for lipid levels, BMI, and smoking. The provided text does not specify whether rs10860227 is among those with cardiometabolic co-associations.

Evidence quality The association of rs10860227 with CRP levels derives from a single multi-trait GWAS (Koskeridis et al., Nature Communications, 2022) that reached genome-wide significance across 797 signals in 283 loci, with 41 of these entirely novel. The multi-trait MTAG design increases sensitivity compared with a single-trait analysis, but also raises the possibility that some loci gain significance through inter-trait correlation rather than direct biological effects on CRP. The provided text does not report the individual sample size, effect estimate, or replication status for rs10860227 specifically. Without independent replication for this locus, the evidence should be treated as preliminary. The MTAG framework is a recognized method in human genetics, which lends analytical credibility to the discovery within these stated limitations.

Lifestyle considerations No lifestyle considerations on file for this variant.